Mizuho Maintains Neutral on Amgen, Raises Price Target to $352

Benzinga Newsdesk www.benzinga.com Positive 54.8%

Neg 0% Neu 0% Pos 54.8%

Mizuho analyst Salim Syed maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $303 to $352.

Comments

No comments yet. Be the first!